How Has Kimberly-Clark’s Revenue and EBITDA Composition Changed Over The Last Five Years?
- The At-Home Tissue Products division has lost 5% revenue share in the last 5 years, most of which was gained by the Feminine Care division
Have more questions on Kimberly-Clark? See the links below:
- What is Kimberly-Clark’s Current Revenue and EBITDA Breakdown?
- What Is Kimberly-Clark’s Fundamental Value Based On Expected 2015 Results?
- By How Much Has Kimberly-Clark’s Revenue & EBITDA Changed In The Last 5 Years?
- How Much Are Kimberly-Clark’s Business Divisions Worth Individually?
- By How Much Is Kimberly-Clark’s Revenue & EBITDA Expected to Change In The Next 5 Years?
- Is Kimberly-Clark Stock Fairly Valued At $135 After A Solid Q1?
- Should You Pick Kimberly-Clark Stock At $120 After A Downbeat Q4?
- Is Kimberly-Clark Stock Fully Priced At $120?
- Which Is A Better Pick – Kimberly-Clark Stock Or IDEXX Laboratories?
- Which Is A Better Consumer Defensive Pick – Kimberly-Clark Or CL Stock?
- Is Kimberly-Clark Stock A Better Pick Over Its Industry Peer?
Notes: